Powered by
Microbix Announces First Shipment of Bioreactor Antigen
Sep 14, 2017 - News Bites Canadian Markets


Corporate Wire Date: 13 September 2017 20:16 EDT


TORONTO, ONTARIO--(Marketwired - Sept. 13, 2017) - Microbix Biosystems Inc. (TSX:MBX), a developer and marketer of biological products and technologies, announces its first full-scale shipment of antigen produced using its new bioreactor manufacturing process, following customer validation.

Microbix' revenues are derived principally from the sales of its antigens for

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox